An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

• Status: Completed
• Trial end date: 2009-08-01

Summary

The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil, once daily (QD), compared to placebo, valsartan and olmesartan in participants with essential hypertension.

• Phase: Phase 3

Details

• Lead Sponsor: Takeda
• Treatments: Azilsartan medoxomil; Olmesartan; Olmesartan Medoxomil; Valsartan